Latest filings (excl ownership)
6-K
Evome Medical Technologies Announces Securities Issuances
17 Jun 24
6-K
Current report (foreign)
3 Jun 24
6-K
Condensed Consolidated Interim Financial Statements
31 May 24
6-K
Posting Q1 Financials, Provides Updates on Strong Q2
30 May 24
6-K
Current report (foreign)
23 Apr 24
10-K
2023 FY
Annual report
16 Apr 24
8-K
LOI Related to Simbex Acquisition Debt is Cancelled
15 Apr 24
8-K
Improves Balance Sheet, Reduces Biodex Acquisition Debt
4 Apr 24
8-K
Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023
1 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
8-K
Departure of Directors or Certain Officers
23 Feb 24
8-K
Other Events
9 Feb 24
8-K
Departure of Directors or Certain Officers
2 Feb 24
8-K
Departure of Directors or Certain Officers
23 Jan 24
8-K
Salona Global Announces Exclusive Partnership with Recenly Launched U.S. Military Veteran (VA) Focused Distribution Company
16 Jan 24
8-K
Other Events
28 Dec 23
8-K
Results of Operations and Financial Condition
20 Nov 23
8-K
Other Events
20 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Other Events
31 Oct 23
8-K
Salona Global Medical Device Corporation Appoints Natalia Vakhitova as New CFO
23 Oct 23
8-K
Entry into a Material Definitive Agreement
18 Sep 23
8-K
Other Events
23 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
16 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Salona Global Extends Biodex Acquisition Debt Duration to July 2025
10 Aug 23
8-K
Departure of Directors or Certain Officers
3 Aug 23
8-K
Departure of Directors or Certain Officers
27 Jul 23
8-K
Annual General & Special Meeting of Shareholders
17 Jul 23
8-K
Salona Global Appoints Michael Seckler, Medical Sales & Marketing Senior Executive, as Interim CEO; Adjusts Management Team with a Focus on Cash Flow
20 Jun 23
8-K
Salona Global Announces Appointment of Lana Newishy to Board of Directors
26 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Completion of Acquisition or Disposition of Assets
7 Apr 23
NT 10-K
Notice of late annual filing
3 Apr 23
10-KT
Annual report (with FYE transition)
31 Mar 23
8-K
Entry into a Material Definitive Agreement
21 Mar 23
UPLOAD
Letter from SEC
15 Mar 23
CORRESP
Correspondence with SEC
7 Mar 23
UPLOAD
Letter from SEC
17 Feb 23
10-Q
2022 Q3
Quarterly report
17 Jan 23
Latest ownership filings
4
Kyle Lowell Wilks
9 Jul 21
4
LESLIE H CROSS
11 Jun 21
3
Kyle Lowell Wilks
28 May 21
3
Jane E Kiernan
28 May 21
3
Kenneth Blair Kashkin
28 May 21
3
LESLIE H CROSS
28 May 21
4
Michael Philip Dalsin
25 May 21
4
ROGER S GREENE
25 May 21
3
Michael Philip Dalsin
24 May 21
3
Michael Philip Dalsin
24 May 21
3
ROGER S GREENE
24 May 21